A group of over 200 stakeholders, including the Alliance for Connected Care and the American Telemedicine Association, urged the DEA to release a revised proposed rule to allow and regulate the prescribing of controlled substances through telehealth. The DEA had previously proposed a rule that would limit telehealth prescriptions of controlled substances, leading to outcry from advocates. A revised rule is seen as crucial for access to mental health and substance use disorder care. Stakeholders emphasized the need for coordination and training among healthcare providers, pharmacies, and regulatory bodies, as well as the potential impact on patient access to care.
Source link
200 Stakeholders Push DEA for Updated Proposed Rule on Virtual Prescribing of Controlled Substances
